However, the direct inhibition of Mcl-1 has several pitfalls [17], such as the fact that these molecules come with a high molecular weight, which, in the context of glioblastoma, might be cumbersome due to the presence of the blood brain barrier [18,19]. The gene discussed is MCL1; the disease is glioblastoma.